Breaking News Instant updates and real-time market news.

ARNA

Arena Pharmaceuticals

$30.89

-0.61 (-1.94%)

07:48
03/20/18
03/20
07:48
03/20/18
07:48

Arena Pharmaceuticals sharply higher after Phase 2 results, analyst action

In pre-market trading the shares were last up over 35.2% to $41.80. At that price next resistance is at $42.74 and then at the 52-week high at $44.50. Support is at the $40.50-$40 area. As previously reported, JPMorgan took its price target up to $48. Needham upgraded the stock to Buy with a $60 price target. Wells Fargo raised its price target from $53 up to $60.

ARNA Arena Pharmaceuticals
$30.89

-0.61 (-1.94%)

03/20/18
JPMS
03/20/18
NO CHANGE
Target $48
JPMS
Neutral
Arena Pharmaceuticals target raised to $48 on positive data at JPMorgan
JPMorgan analyst Jessica Fye raised her price target for Arena Pharmaceuticals to $48 from $45 citing the positive efficacy data in last night's Phase II study results for ulcerative colitis. The likelihood of Phase III success should be considered higher based on the data, Fye tells investors in a research note. While not the pure "best case" scenario with no second degree heart block, the dataset represents a "clear win relative to expectations," the analyst adds. Fye sees the news as a "key positive step" in the ongoing evolution of Arena. The analyst keeps a Neutral rating on the shares.
03/20/18
NEED
03/20/18
UPGRADE
NEED
Buy
Arena Pharmaceuticals upgraded to Buy from Hold at Needham
03/20/18
WELS
03/20/18
NO CHANGE
Target $60
WELS
Outperform
Arena Pharmaceuticals price target raised to $60 from $53 at Wells Fargo
Wells Fargo analyst Jim Birchenough raised his price target for Arena Pharmaceuticals to $60 form $53 following positive OASIS phase 2 data for etrasimod in ulcerative colitis. The analyst reiterates an Outperform rating on the shares.
03/20/18
NEED
03/20/18
UPGRADE
Target $60
NEED
Buy
Arena Pharmaceuticals upgraded to Buy at Needham on phase 2 UC data
As reported earlier, Needham analyst Alan Carr upgraded Arena Pharmaceuticals to Buy from Hold with a price target of $60. Carr cites the company's "impressive results" from its Phase 2 Ulcerative Colitis study unveiled yesterday, noting that the the safety and tolerability data components are also "encouraging". The analyst adds that the favorable outcome warrants an update to his pricing model, particularly in light of "substantial" unmet need in the Inflammation space where there are few S1P modulators currently in development.

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$1,811.20

-46.54 (-2.51%)

, GOOG

Alphabet

$1,134.97

-15.53 (-1.35%)

15:31
05/23/19
05/23
15:31
05/23/19
15:31
Periodicals
Amazon-backed self-driving unicorn Aurora buys lidar maker, Forbes says »

According to Alan Ohnsman…

AMZN

Amazon.com

$1,811.20

-46.54 (-2.51%)

GOOG

Alphabet

$1,134.97

-15.53 (-1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 03

    Jun

  • 19

    Jun

  • 25

    Jun

  • 27

    Oct

WPG

Washington Prime

$4.48

0.02 (0.45%)

15:20
05/23/19
05/23
15:20
05/23/19
15:20
Options
Notable put buy in Washington Prime »

Notable put buy in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

SPLK

Splunk

$128.52

-7.28 (-5.36%)

15:19
05/23/19
05/23
15:19
05/23/19
15:19
Options
Splunk options imply 9.0% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 13

    Jun

  • 09

    Jul

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
05/23/19
05/23
15:17
05/23/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOS

Canada Goose

$47.50

-1.605 (-3.27%)

15:16
05/23/19
05/23
15:16
05/23/19
15:16
Periodicals
Breaking Periodicals news story on Canada Goose »

Hedgeye adds Canada Goose…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
05/23/19
05/23
15:16
05/23/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DTE

DTE Energy

$128.90

0.6 (0.47%)

15:14
05/23/19
05/23
15:14
05/23/19
15:14
Hot Stocks
DTE Energy officer Mark Stiers sells almost $1.3M in company shares »

DTE Energy officer Mark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

  • 12

    Jun

DNR

Denbury Resources

$1.57

-0.15 (-8.72%)

15:10
05/23/19
05/23
15:10
05/23/19
15:10
Options
Denbury Resources draws call buying as shares probe 2019 lows »

Denbury Resources draws…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

15:10
05/23/19
05/23
15:10
05/23/19
15:10
General news
Treasury Market Summary »

Treasury Market Summary:…

WETF

WisdomTree

$6.13

-0.305 (-4.74%)

15:06
05/23/19
05/23
15:06
05/23/19
15:06
Hot Stocks
WisdomTree CEO Jonathan Steinberg buys over $496K in shares »

WisdomTree CEO Jonathan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

HPQ

HP Inc.

$19.16

-0.13 (-0.67%)

15:04
05/23/19
05/23
15:04
05/23/19
15:04
Options
HP Inc. options imply 7.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

TMUS

T-Mobile

$75.93

-0.42 (-0.55%)

, S

Sprint

$6.91

0.22 (3.29%)

15:02
05/23/19
05/23
15:02
05/23/19
15:02
Hot Stocks
Pennsylvania PUC approves application related to proposed Sprint/T-Mobile merger »

The Pennsylvania Public…

TMUS

T-Mobile

$75.93

-0.42 (-0.55%)

S

Sprint

$6.91

0.22 (3.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

MAXR

Maxar Technologies

$7.93

0.78 (10.91%)

14:59
05/23/19
05/23
14:59
05/23/19
14:59
Hot Stocks
Breaking Hot Stocks news story on Maxar Technologies »

Maxar Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMG

Chipotle

$666.60

-39.45 (-5.59%)

14:55
05/23/19
05/23
14:55
05/23/19
14:55
Hot Stocks
Chipotle disagrees with downgrade, sees no major impact from African swine fever »

After BMO Capital analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

MAXR

Maxar Technologies

$7.93

0.78 (10.91%)

14:55
05/23/19
05/23
14:55
05/23/19
14:55
Hot Stocks
Maxar selected to build, fly first element of NASA's Lunar Gateway »

Maxar Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLF

Herbalife Nutrition

$43.33

-1.03 (-2.32%)

14:55
05/23/19
05/23
14:55
05/23/19
14:55
Options
Herbalife put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRNT

Verint

$54.60

-6.61 (-10.80%)

14:54
05/23/19
05/23
14:54
05/23/19
14:54
Recommendations
Verint analyst commentary  »

Oppenheimer says buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 20

    Jun

ADSK

Autodesk

$168.15

-5.96 (-3.42%)

14:49
05/23/19
05/23
14:49
05/23/19
14:49
Options
Autodesk options imply 8.6% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 12

    Jun

GWR

Genesee & Wyoming

$85.51

-0.55 (-0.64%)

, BX

Blackstone

$40.81

-0.89 (-2.13%)

14:48
05/23/19
05/23
14:48
05/23/19
14:48
Periodicals
Genesee & Wyoming pursued by Blackstone, Brookfield, others, Bloomberg says »

Blackstone (BX),…

GWR

Genesee & Wyoming

$85.51

-0.55 (-0.64%)

BX

Blackstone

$40.81

-0.89 (-2.13%)

BAM

Brookfield

$46.47

-0.33 (-0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

  • 19

    Jun

  • 08

    Aug

  • 13

    Nov

NXPI

NXP Semiconductors

$90.85

-2.79 (-2.98%)

14:45
05/23/19
05/23
14:45
05/23/19
14:45
Options
NXP Semiconductors call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 29

    May

  • 13

    Jun

FE

FirstEnergy

$42.94

0.31 (0.73%)

14:36
05/23/19
05/23
14:36
05/23/19
14:36
Periodicals
Breaking Periodicals news story on FirstEnergy »

Ohio advances bill that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HII

Huntington Ingalls

$202.83

-6.34 (-3.03%)

14:35
05/23/19
05/23
14:35
05/23/19
14:35
Hot Stocks
Huntington Ingalls VP William Ermatinger sells almost $400K in company shares »

Huntington Ingalls VP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

QRVO

Qorvo

$59.38

-0.83 (-1.38%)

14:35
05/23/19
05/23
14:35
05/23/19
14:35
Options
Qorvo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UIS

Unisys

$9.44

-0.3 (-3.08%)

14:31
05/23/19
05/23
14:31
05/23/19
14:31
Initiation
Unisys initiated  »

Unisys initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MAXR

Maxar Technologies

$8.20

1.05 (14.69%)

14:28
05/23/19
05/23
14:28
05/23/19
14:28
Hot Stocks
NASA confirms contract with maximum $375M value awarded to Maxar Technologies »

NASA announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.